The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Homocysteine and cardiovascular disease: a review of the evidence
Abstract
Elevated homocysteine (HCY) levels can be caused by a number of factors, including folate and B-vitamin deficiency, pre-existing atherosclerotic disease, diabetes and various drugs. Epidemiological evidence, as well as data from retrospective and prospective studies, supports an association between elevated HCY levels and increased risk of cardiovascular disease (CVD). However, whether lowering HCY levels by administration of folate and vitamins B 6 and B 12 is associated with any significant decrease in vascular risk remains the subject of ongoing debate. Although the major studies that have reported to date show that vitamin supplementation was associated with a decrease in HCY levels, this failed to have any significant effect on cardiovascular risk. Furthermore, although some lipid-modifying treatments have been shown to increase HCY levels, there is no evidence that this attenuates or compromises the beneficial effects of such treatments on cardiovascular risk. Taken together, these data suggest that HCY is a marker, rather than a cause, of CVD and therefore do not provide support for routine screening for and treatment of elevated HCY to prevent CVD. Data from ongoing clinical trials are awaited to clarify this issue.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Boushey, C. J. (1995) · JAMA · doi:10.1001/jama.1995.03530130055028 · Cited by 3,584
Homocysteine and Risk of Ischemic Heart Disease and Stroke: A Meta-analysis
Homocysteine Studies Collaboration (2002) · JAMA · doi:10.1001/jama.288.16.2015 · Cited by 2,059
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
Wald, D. S., Law, M., & Morris, J. K. (2002) · BMJ · doi:10.1136/bmj.325.7374.1202 · Cited by 1,946
Plasma Homocysteine as a Risk Factor for Vascular Disease: The European Concerted Action Project
Graham, I. M. (1997) · JAMA · doi:10.1001/jama.1997.03540460039030 · Cited by 1,738
Homocysteine Lowering with Folic Acid and B Vitamins in Vascular Disease
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa060900 · Cited by 1,729
A Prospective Study of Plasma Homocyst(e)ine and Risk of Myocardial Infarction in US Physicians
Stampfer, M. J. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03490070059042 · Cited by 1,709
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442
Toole, J. F., Malinow, M. R., Chambless, L. E., Spence, J. D., Pettigrew, L. C., Howard, V. J., Sides, E. G., Wang, C.-H., & Stampfer, M. (2004) · JAMA · doi:10.1001/jama.291.5.565 · Cited by 1,391
Association between Plasma Homocysteine Concentrations and Extracranial Carotid-Artery Stenosis
Selhub, J., Jacques, P. F., Bostom, A. G., D'Agostino, R. B., Wilson, P. W. F., Belanger, A. J., O'Leary, D. H., Wolf, P. A., Schaefer, E. J., & Rosenberg, I. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320502 · Cited by 1,216
Selhub, J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.217 · Cited by 1,186
Homocyst(e)ine and Cardiovascular Disease: A Critical Review of the Epidemiologic Evidence
Eikelboom, J. W., Lonn, E., Genest, J., Hankey, G., & Yusuf, S. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-5-199909070-00008 · Cited by 908
Perry, I. J., Morris, R. W., Ebrahim, S. B., Shaper, A. G., Refsum, H., & Ueland, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92407-8 · Cited by 883
Stamler, J. S., Osborne, J. A., Jaraki, O., Rabbani, L. E., Mullins, M., Singel, D., & Loscalzo, J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116187 · Cited by 860
Brattström, L., Wilcken, D. E. L., Öhrvik, J., & Brudin, L. (1998) · Circulation · doi:10.1161/01.cir.98.23.2520 · Cited by 659
Serum Total Homocysteine and Coronary Heart Disease
ARNESEN, E., REFSUM, H., BØNAA, K. H., UELAND, P. M., FØRDE, O. H., & NORDREHAUG, J. E. (1995) · International Journal of Epidemiology · doi:10.1093/ije/24.4.704 · Cited by 651
Folsom, A. R., Nieto, F. J., McGovern, P. G., Tsai, M. Y., Malinow, M. R., Eckfeldt, J. H., Hess, D. L., & Davis, C. E. (1998) · Circulation · doi:10.1161/01.cir.98.3.204 · Cited by 603
Decreased Rate of Coronary Restenosis after Lowering of Plasma Homocysteine Levels
Schnyder, G., Roffi, M., Pin, R., Flammer, Y., Lange, H., Eberli, F. R., Meier, B., Turi, Z. G., & Hess, O. M. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011364 · Cited by 532
Hofmann, M. A., Lalla, E., Lu, Y., Gleason, M. R., Wolf, B. M., Tanji, N., Ferran, L. J., Kohl, B., Rao, V., Kisiel, W., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci10588 · Cited by 529
Alfthan, G., Pekkanen, J., Jauhiainen, M., Pitkäniemi, J., Karvonen, M., Tuomilehto, J., Salonen, J. T., & Ehnholm, C. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)90078-7 · Cited by 527
Nygård, O., Refsum, H., Ueland, P., & Vollset, S. (1998) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/67.2.263 · Cited by 444
Homocysteine and stroke: evidence on a causal link from mendelian randomisation
Casas, J. P., Bautista, L. E., Smeeth, L. L., Sharma, P. K., & Hingorani, A. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17742-3 · Cited by 444
Bazzano, L. A., Reynolds, K., Holder, K. N., & He, J. (2006) · JAMA · doi:10.1001/jama.296.22.2720 · Cited by 426
Kanani, P. M., Sinkey, C. A., Browning, R. L., Allaman, M., Knapp, H. R., & Haynes, W. G. (1999) · Circulation · doi:10.1161/01.cir.100.11.1161 · Cited by 418
Increased intake of calcium reverses vitamin B12 malabsorption induced by metformin
Bauman, W. A., Shaw, S., Jayatilleke, E., Spungen, A. M., & Herbert, V (2000) · Diabetes Care · doi:10.2337/diacare.23.9.1227 · Cited by 412
Schnyder, G., Roffi, M., Flammer, Y., Pin, R., & Hess, O. M. (2002) · JAMA · doi:10.1001/jama.288.8.973 · Cited by 379
A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
Verhoef, P., Hennekens, C. H., Malinow, M. R., Kok, F. J., Willett, W. C., & Stampfer, M. J. (1994) · Stroke · doi:10.1161/01.str.25.10.1924 · Cited by 379
Wald, N. J., Watt, H. C., Law, M. R., Weir, D. G., McPartlin, J., & Scott, J. M. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.8.862 · Cited by 369
Mechanisms of homocysteine‐induced atherothrombosis
LENTZ, S. R. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01364.x · Cited by 363
Homocyst(e)ine and Risk of Cardiovascular Disease in the Multiple Risk Factor Intervention Trial
Evans, R. W., Shaten, B. J., Hempel, J. D., Cutler, J. A., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.10.1947 · Cited by 342
Folate Therapy and In-Stent Restenosis after Coronary Stenting
Lange, H., Suryapranata, H., De Luca, G., Börner, C., Dille, J., Kallmayer, K., Pasalary, M. N., Scherer, E., & Dambrink, J.-H. E. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032845 · Cited by 336
Lewis, S. J., Ebrahim, S., & Smith, G. D. (2005) · BMJ · doi:10.1136/bmj.38611.658947.55 · Cited by 306
A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.
Chasan-Taber, L., Selhub, J., Rosenberg, I. H., Malinow, M. R., Terry, P., Tishler, P. V., Willett, W., Hennekens, C. H., & Stampfer, M. J. (1996) · Journal of the American College of Nutrition · doi:10.1080/07315724.1996.10718578 · Cited by 273
Bots, M. L., Launer, L. J., Lindemans, J., Hoes, A. W., Hofman, A., Witteman, J. C. M., Koudstaal, P. J., & Grobbee, D. E. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.38 · Cited by 260
Enzyme conversion immunoassay for determining total homocysteine in plasma or serum
Frantzen, F., Faaren, A. L., Alfheim, I., & Nordhei, A. K. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.2.311 · Cited by 252
Vitamin Intervention for Stroke Prevention Trial: An Efficacy Analysis
Spence, J. D., Bang, H., Chambless, L. E., & Stampfer, M. J. (2005) · Stroke · doi:10.1161/01.str.0000185929.38534.f3 · Cited by 244
Plasma Total Homocysteine, B Vitamins, and Risk of Coronary Atherosclerosis
Verhoef, P., Kok, F. J., Kruyssen, D. A. C. M., Schouten, E. G., Witteman, J. C. M., Grobbee, D. E., Ueland, P. M., & Refsum, H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.5.989 · Cited by 234
Ford, E. S., Smith, S. J., Stroup, D. F., Steinberg, K. K., Mueller, P. W., & Thacker, S. B. (2002) · International Journal of Epidemiology · doi:10.1093/ije/31.1.59 · Cited by 230
Vitamin-B 12 Status of Patients on Long-term Metformin Therapy
Tomkin, G. H., Hadden, D. R., Weaver, J. A., & Montgomery, D. A. D. (1971) · BMJ · doi:10.1136/bmj.2.5763.685 · Cited by 225
Homocysteine Hypothesis for Atherothrombotic Cardiovascular Disease
Kaul, S., Zadeh, A. A., & Shah, P. K. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.04.086 · Cited by 176
Homocysteine: Role and implications in atherosclerosis
Guthikonda, S., & Haynes, W. G. (2006) · Current Atherosclerosis Reports · doi:10.1007/s11883-006-0046-4 · Cited by 160
B-Vitamin Treatment Trialists' Collaboration (2006) · American Heart Journal · doi:10.1016/j.ahj.2005.04.025 · Cited by 156
Drugs Affecting Homocysteine Metabolism
Desouza, C. V., Keebler, M., McNamara, D. B., & Fonseca, V. A. (2002) · Drugs · doi:10.2165/00003495-200262040-00005 · Cited by 129
van den Berg, M., Stehouwer, C. D. A., Bierdrager, E., & Rauwerda, H. (1996) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.16.1.165 · Cited by 124
Plasma Total Homocysteine and Risk of Angina Pectoris With Subsequent Coronary Artery Bypass Surgery
Verhoef, P., Hennekens, C. H., Allen, R. H., Stabler, S. P., Willett, W. C., & Stampfer, M. J. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00874-0 · Cited by 96
Giral, P., Bruckert, É., Jacob, N., Chapman, M. J., Foglietti, M. J., & Turpin, G. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00474-3 · Cited by 92
Carlsen, S. M., Følling, I., Grill, V., Bjerve, K. S., Schneede, J., & Refsum, H. (1997) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365519709084603 · Cited by 82
Derosa, G., D’Angelo, A., Ragonesi, P. D., Ciccarelli, L., Piccinni, M. N., PRICOLO, F., SALVADEO, S. A. T., Montagna, L., Gravina, A., Ferrari, I., et al. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00756.x · Cited by 82
Effect of Drugs on Homocysteine Concentrations
Dierkes, J., & Westphal, S. (2005) · Seminars in Vascular Medicine · doi:10.1055/s-2005-872398 · Cited by 81
Kılıçdağ, E. B., Bağış, T., Zeyneloğlu, H. B., Tarım, E., Aslan, E., Haydardedeoğlu, B., & Erkanlı, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh700 · Cited by 78
Genest, J., Frohlich, J., & Steiner, G. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.022 · Cited by 51
The effect of fibrates and other lipid-lowering drugs on plasma homocysteine levels
Dierkes, J., Westphal, S., & Luley, C. H. (2004) · Expert Opinion on Drug Safety · doi:10.1517/eods.3.2.101.27336 · Cited by 40
Cited by
Homocysteine lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., Lathyris, D., & Salanti, G. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub2 · Cited by 520
A Review on Various Uses of N-Acetyl Cysteine.
Mokhtari, V., Afsharian, P., Shahhoseini, M., Kalantar, S. M., & Moini, A. (2017) · PubMed · doi:10.22074/cellj.2016.4872 · Cited by 304
Whiteman, M., & Moore, P. K. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00645.x · Cited by 261
The role of epigenetics in renal ageing
Shiels, P. G., McGuinness, D., Eriksson, M., Kooman, J. P., & Stenvinkel, P. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.78 · Cited by 114
Homocysteine-lowering interventions for preventing cardiovascular events
Martí-Carvajal, A. J., Solà, I., & Lathyris, D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006612.pub4 · Cited by 113
Metadata
- Authors
- Wierzbicki, A. S.
- Venue
- Diabetes and Vascular Disease Research
- Publisher
- SAGE Publications
- Published
- 2007-06
- Volume
- 4
- Issue
- 2
- Pages
- 143-149
- ISSN
- 1479-1641 (ISSN-L)
- 1752-8984
- OpenAlex
- W2144393300
- Cited by
- 287
- References
- 54
- FWCI
- 12.41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.